Site-agnostic PARP-inhibitor maintenance therapy of advanced stage BRCA2-mutated gastric-type endocervical adenocarcinoma: A case report

• Lauren Jill Tostrud,
• Sahana Somasegar,
• Malte Renz

Affiliations

Lauren Jill Tostrud

Department of Obstetrics & Gynecology, Stanford University School of Medicine, Palo Alto, CA, United States

Sahana Somasegar

Gynecologic Oncology Division, Stanford University School of Medicine, Palo Alto, CA, United States

Malte Renz

Stanford University, Stanford, CA, United States; Department of Obstetrics & Gynecology, Heinrich-Heine University Düsseldorf, Germany; Corresponding author at: Moorenstrasse 5, 40225 Düsseldorf, Germany.